NIEYX
Price
$17.80
Change
+$0.08 (+0.45%)
Updated
Jun 2 closing price
Net Assets
332.3M
VTMNX
Price
$23.25
Change
+$0.06 (+0.26%)
Updated
Jun 2 closing price
Net Assets
304.26B
Interact to see
Advertisement

NIEYX vs VTMNX

Header iconNIEYX vs VTMNX Comparison
Open Charts NIEYX vs VTMNXBanner chart's image
NIEYX vs VTMNX Comparison Chart in %
View a ticker or compare two or three
VS
NIEYX vs. VTMNX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NIEYX is a Buy and VTMNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTMNX has more cash in the bank: 304B vs. NIEYX (332M). VTMNX pays higher dividends than NIEYX: VTMNX (2.61) vs NIEYX (2.45). NIEYX was incepted earlier than VTMNX: NIEYX (13 years) vs VTMNX (25 years). NIEYX (0.93) is less costly to investors than VTMNX (0.03). NIEYX is a more actively managed with annual turnover of: 230.46 vs. VTMNX (4.00). NIEYX has a lower initial minimum investment than VTMNX: NIEYX (1000000) vs VTMNX (5000000). VTMNX annual gain was more profitable for investors over the last year : 29.00 vs. NIEYX (2.17). VTMNX return over 5 years is better than : 40.65 vs. NIEYX (-24.35).
NIEYXVTMNXNIEYX / VTMNX
Total Expense Ratio0.790.032,633%
Annual Report Gross Expense Ratio0.930.033,100%
Fund Existence13 years25 years-
Gain YTD6.23515.49740%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets332M304B0%
Annual Yield % from dividends2.452.6194%
Returns for 1 year2.1729.007%
Returns for 3 years-10.6660.05-18%
Returns for 5 years-24.3540.65-60%
Returns for 10 years8.81107.248%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOB37.810.48
+1.29%
Live Oak Bancshares
PKBK31.070.36
+1.19%
Parke Bancorp
IPCXU10.64N/A
N/A
Inflection Point Acquisition Corp
STN74.84-1.53
-2.00%
Stantec
ESLA1.08-0.04
-3.57%
Estrella Immunopharma